Autopsy report · NCT02072616

Detection of Circulating Tumor Cells for the Diagnostic of Pancreatic Adenocarcinoma.

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Analysis not possible at the stage”

The sponsor’s own words in the registry.

Life of this trial

Registered 7 months before it started.
Ran for about 7 years 5 months before it stopped.
101 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Na
Sponsor: University Hospital, Rouen
Sponsor type: University, hospital or other
Conditions: Circulating Tumor Cells; Pancreatic Adenocarcinoma; Circulating Tumor DNA (KRAS); CA 19.9
Interventions: Pancreatic adenocarcinoma diagnosis
Participants: 101
Sites: 1
Countries: France

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.